search

Kiran Sunkari

Director, Research Science and Advanced Analytics

A man with short dark hair, wearing glasses and a red-and-white striped collared shirt, poses against a plain white background.

Kiran Sunkari is a Director, Research Science and Advanced Analytics at Inovalon. He works primarily on healthcare data analytics to achieve quality of care by unlocking important patterns and trends around diagnosis, treatment, and continued care for patients across commercial, Fee-for-Service Medicare (100%), Medicare Part D (100%), Medicare Advantage, and managed Medicaid populations. Kiran also supports life sciences and provider clients in areas of healthcare utilization and cost modeling.

Prior to joining Inovalon, Kiran was a Research Scientist II with Avalere Health. Before that, Kiran was a Senior Manager, Advanced Analytics for IQVIA, working on clinical quality measure development, NQF endorsed measures, physicians’ pay for performance, cost of care programs, and NCQA HEDIS® certification by utilizing large claims databases of various health plans, outcomes measurement, and performing statistical analyses for academic research studies.

Kiran.Sunkari@inovalon.com
Authored Content
Placeholder
Cardiovascular

Real-World Adherence and Persistence Among U.S. Medicare Beneficiaries Initiating Advanced Lipid Lowering Therapies

Accepted for presentation at American Society for Preventive Cardiology 2026 Congress on CVD Prevention. Findings available upon request. Contact us for more information.

Placeholder
Fee-for-service medicare

Medicare Advantage vs. Traditional Fee-for-Service Medicare: Different Populations, Different Outcomes

Accepted for presentation at Academy of Managed Care Pharmacy. Findings available upon request. Contact us for more information.

Placeholder
Hematology, oncology

Outcomes of Inpatient and Outpatient Chimeric Antigen Receptor T-Cell Therapy in Newly Authorized Treatment Centers in the United States

Accepted for presentation at American Society of Hematology (ASH). Findings available upon request. Contact us for more information.

Placeholder
Other, real-world evidence

Trends in Opioid Use Disorder Diagnoses, Hospitalizations, and Receipt of Recommended Therapy (2021–2024)

This retrospective analysis used Inovalon’s MORE² Registry® — a nationally representative closed-claims database — to evaluate trends in opioid use disorder (OUD) from 2021–2024 across three insured populations: commercially insured, Managed Medicaid, and Medicare Advantage.

Read More →
An older woman smiles while standing next to a male doctor who is showing her information on a tablet. They appear to be in a medical office with charts on the wall in the background.
Life Sciences

Medicare Advantage vs. Traditional Fee-for-Service Medicare: Different Populations, Different Outcomes

This study explores important differences in MA vs FFS populations and outcomes, challenging previous research and sharing key insights.

Read More →
Placeholder
Social determinants and health equity

Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured Before and After Transition to Medicare Advantage or Traditional Medicare Fee-for-Service

Accepted for presentation at ISPOR 2023. Findings available upon request. Contact us for more information.

Share